To receive our monthly eNews as well as event notices and other updates, just enter your email address.
Take a moment to learn more about NYAM's activities and events.
NYAM Fellow Dr. David G. Nathan, MD of Cambridge, Mass., Robert A. Stranahan Distinguished Professor of Pediatrics and Professor of Medicine at Harvard Medical School and president emeritus of the Dana-Farber Cancer Institute, received an honorary doctor of science degree at Clarkson University's 119th Commencement on May 12.
Nathan is medical research pioneer in the field of hematology. The degree was awarded for his "his role as a dedicated physician and medical research pioneer, whose advances in research have had a profound and lasting impact on our understanding and treatment of hematological diseases and cancer; and for his role as an innovative administrator and an influential educator, under whose wisdom and guidance several generations of leading physicians have trained."
In addressing the Class of 2012, Nathan said, "Aristotle once called friendship one soul inhabiting two bodies. Given the joy of friendship and in tribute to the friends that all of you have made here, my advice to you today is to treasure your friendships. ...
"Much of life's accomplishments are based on the capacity to work well with colleagues of all types and backgrounds. Friendship is the fundamental basis of teamwork. And only the latter will lead to the solutions of life's challenges for which Clarkson has so ably prepared you. ... As a new friend and honorary classmate, I salute you."
Nathan's research has focused on the inherited disorders of red cells and granulocytes and particularly on Thalassemia and sickle cell anemia. His work has had a profound and lasting impact on the treatment of patients suffering from hematological diseases as well as different forms of cancer.
Over the course of his nearly 50-year career, his advances in medicine include the development of the first prenatal diagnostic test for thalassemia and sickle cell anemia, the introduction of effective treatment of iron overload and the only FDA approved drug for the amelioration of sickle cell anemia symptoms.
A graduate of Harvard College, Nathan received his MD in 1955 from Harvard Medical School. He was an intern and senior resident in medicine at the then Peter Bent Brigham Hospital and a clinical associate at the National Cancer Institute. From 1959 to 1966, he was a hematologist at the Peter Bent Brigham Hospital and then became chief of the Division of Hematology and Oncology at Children's Hospital and Dana-Farber Cancer Institute. From 1985 to 1995, he was physician-in-chief of the Children's Hospital, and from 1995 to 2000 he was president of Dana Farber Cancer Institute.
Posted on May 15, 2012
Contact:
Andrew J. Martin
Director of Communications
The New York Academy of Medicine
1216 Fifth Avenue
New York, New York 10029
212-822-7285
amartin@nyam.org
Reporters: to arrange interviews with NYAM medical and urban health experts, contact
Andrew J. Martin, Director of Communications
212-822-7285 / amartin@nyam.org
The 2012-2013 Duncan Clark Lecture - The Affordable Care Act: An Insider’s View
Featured Speaker: Sherry Glied, PhD, former Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services
November 19, 2012 - The NYAM Section on Health Care Delivery welcomes Sherry Glied, PhD, former Assistant Secretary for Planning and Evaluation in the U.S. Department of Health and Human Services, who will deliver the 2012-2013 Duncan Clark Lecture on "The Affordable Care Act: An Insider's View."
Learn more »
The New York Academy of Medicine with support from the New York State Heath Foundation released a new report, Federal Health Care Reform in New York State: A Population Health Perspective.
This report identifies opportunities that build on both the Patient Protection and Affordable Health Care Act (ACA) and New York’s ongoing efforts toward improving the health of its 19 million residents.
Read press release
Read report
